# OTLC (Oncotelic Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Oncotelic Therapeutics, Inc. reported $393.8M in total assets and net income of $247.5M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/OTLC
- Markdown: https://convexityos.com/fundamentals/OTLC.md
- SEC CIK: 0000908259
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000908259&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$5.46M | Operating profit |
| Net Income | FY 2025 | $247.5M | GAAP bottom line |
| Diluted EPS | FY 2025 | $0.54 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $64K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | $70K | -- | -- | $1.74M | -- | -- | -- | -- |
| Research & Development | $4.4K | -- | $61K | $757K | $3.66M | $4.30M | $1.37M | $650K | $10.47M | $8.76M |
| Total Operating Expenses | $3.19M | $3.58M | $6.72M | $9.72M | $9.13M | $9.33M | $4.31M | $713K | $13.84M | $13.76M |
| **Operating Income** | -$3.19M | -$3.58M | -$6.65M | -$9.72M | -$9.13M | -$7.58M | -$4.31M | -$713K | -$13.84M | -$13.76M |
| **EBITDA** | -- | -- | -- | -- | -$9.06M | -$7.22M | -$4.25M | -$677K | -$13.83M | -$13.74M |
| Interest Income | -- | -- | -- | -- | -- | -- | $123 | $16K | $35K | $106K |
| Interest Expense | -- | -- | $1.04M | $2.97M | $2.00M | $2.00M | $749K | -- | -- | -- |
| Income Before Tax | $360.6M | -$4.78M | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $111.5M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | $249.3M | -$4.52M | -$7.90M | $5.09M | -$9.39M | -$9.50M | -$6.64M | -$713K | -$13.81M | -$13.65M |
| Basic EPS | $0.59 | $0.01 | -$0.02 | $0.01 | -$0.03 | -$0.11 | -$0.11 | -$0.12 | -$0.52 | -$0.51 |
| **Diluted EPS** | $0.59 | -$0.01 | -$0.02 | $0.01 | -$0.03 | -$0.11 | -$0.11 | -$0.12 | -$0.52 | -$0.51 |
| Basic Shares Outstanding | 421.0M | 404.4M | 384.1M | 384.1M | 303.1M | 88.1M | 60.0M | 6.1M | 26.5M | 26.5M |
| Diluted Shares Outstanding | 422.2M | 404.4M | 396.2M | 457.3M | 303.1M | 88.1M | 60.0M | 6.1M | 26.5M | 26.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | $250K | -- | -- | -- | -- | -- | -- |
| Research & Development | $1.6K | $345 | $795 | $3.3K | $426 | $297 | $297 | -- |
| Total Operating Expenses | $233K | $1.09M | $1.85M | $2.53M | $491K | $66K | $101K | $31K |
| **Operating Income** | -$233K | -$844K | -$1.85M | -$2.53M | -$491K | -$66K | -$101K | -$31K |
| Interest Expense | $287K | $318K | -- | -- | $231K | $208K | -- | -- |
| **Net Income** | -$1.11M | $388K | -$2.19M | $250.4M | -$1.05M | $278K | -$299K | -$601K |
| Basic EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| Basic Shares Outstanding | 457.2M | 447.4M | 443.8M | -- | 426.4M | 408.3M | 407.4M | -- |
| Diluted Shares Outstanding | 457.2M | 467.9M | 443.8M | -- | 426.4M | 452.8M | 407.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $89K | $86K | $170K | $241K | $569K | $474K | $82K | $2.5K | $1.11M | $3.54M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | $8.51M |
| **Cash & Short-Term Investments** | $89K | $86K | $170K | $241K | $569K | $474K | $82K | $2.5K | $1.11M | $12.00M |
| Accounts Receivable, Net | $51K | $19K | $19K | $20K | $20K | $20K | $150K | -- | -- | -- |
| **Total Current Assets** | $1.20M | $134K | $272K | $303K | $627K | $616K | $273K | $2.5K | $1.14M | $14.07M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | $48K | -- | $2.0K | $11K |
| Goodwill | $2.79M | $2.79M | $5.99M | $12.07M | $21.06M | $21.06M | $21.06M | -- | -- | -- |
| Intangible Assets | -- | -- | -- | -- | $822K | $873K | $925K | $976K | -- | -- |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | $1.77M | -- | -- |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | $33K | $33K |
| **Total Non-Current Assets** | $391.9M | $26.54M | $29.74M | $35.81M | $22.99M | $23.05M | $23.41M | $2.75M | $35K | $44K |
| **Total Assets** | $393.1M | $26.68M | $30.01M | $36.12M | $23.61M | $23.66M | $23.68M | $2.75M | $1.17M | $14.11M |
| Accounts Payable | $1.64M | $1.69M | $1.66M | $332K | $1.93M | $1.94M | $1.79M | $915K | $788K | $310K |
| Short-Term Debt | -- | $2.42M | $1.77M | $390K | $359K | $95K | -- | -- | -- | -- |
| **Total Current Liabilities** | $18.14M | $19.20M | $16.50M | $16.92M | $15.45M | $11.18M | $6.78M | $283K | $1.65M | $1.61M |
| **Total Non-Current Liabilities** | $113.2M | $0 | $1.90M | $0 | $0 | $0 | $0 | $0 | $6.6K | $0 |
| **Total Liabilities** | $131.4M | $19.20M | $18.40M | $16.92M | $15.45M | $11.18M | $6.78M | $283K | $1.66M | $1.61M |
| **Total Debt (incl. Leases)** | -- | $2.42M | $1.77M | $390K | $359K | $95K | -- | -- | -- | -- |
| Common Stock | $4.43M | $4.07M | $3.99M | $3.92M | $3.75M | $906K | $841K | $68K | $265K | $265K |
| Retained Earnings | $211.2M | -$38.04M | -$33.52M | -$25.93M | -$31.02M | -$21.63M | -$12.13M | -$5.49M | -$292.3M | -$278.5M |
| **Total Stockholders' Equity** | $262.8M | $8.25M | $12.13M | $19.41M | $7.96M | $11.77M | $16.90M | $2.46M | -$484K | $12.50M |
| Total Equity | $261.7M | $7.48M | $11.61M | $19.19M | $8.16M | $12.48M | $16.90M | $2.46M | -$484K | $12.50M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $64K | $186K | $64K | $89K | $409K | $88K | $79K | $86K |
| **Cash & Short-Term Investments** | $64K | $186K | $64K | $89K | $409K | $88K | $79K | $86K |
| Accounts Receivable, Net | $2.1K | $2.1K | $2.1K | $51K | $4.0K | $19K | $19K | $19K |
| **Total Current Assets** | $1.27M | $1.46M | $2.07M | $1.20M | $1.61M | $138K | $125K | $134K |
| Goodwill | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M |
| **Total Non-Current Assets** | $392.5M | $393.3M | $391.9M | $391.9M | $26.54M | $26.54M | $26.54M | $26.54M |
| **Total Assets** | $393.8M | $394.8M | $394.0M | $393.1M | $28.16M | $26.68M | $26.67M | $26.68M |
| Accounts Payable | $1.73M | $1.83M | $1.70M | $1.64M | $1.69M | $1.71M | $1.69M | $1.69M |
| Short-Term Debt | -- | -- | -- | -- | -- | $2.72M | $2.58M | $2.42M |
| **Total Current Liabilities** | $18.04M | $17.91M | $18.40M | $18.14M | $20.08M | $19.29M | $19.48M | $19.20M |
| **Total Non-Current Liabilities** | $113.5M | $113.4M | $113.3M | $113.2M | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $131.5M | $131.3M | $131.7M | $131.4M | $20.08M | $19.29M | $19.48M | $19.20M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | $2.72M | $2.58M | $2.42M |
| Common Stock | $4.58M | $4.57M | $4.44M | $4.43M | $4.39M | $4.08M | $4.08M | $4.07M |
| Retained Earnings | $208.3M | $209.4M | $209.0M | $211.2M | -$39.11M | -$38.06M | -$38.34M | -$38.04M |
| **Total Stockholders' Equity** | $263.5M | $264.6M | $263.3M | $262.8M | $9.05M | $8.30M | $8.02M | $8.25M |
| Total Equity | $262.3M | $263.4M | $262.2M | $261.7M | $8.08M | $7.39M | $7.18M | $7.48M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $249.0M | -$4.78M | -$8.21M | $4.68M | -$10.52M | -$9.97M | -$6.64M | -$2.74M | -$13.81M | -$13.65M |
| Depreciation & Amortization | -- | -- | -- | -- | $62K | $364K | $61K | $36K | $9.0K | $19K |
| Stock-Based Compensation | $2.38M | $0 | $0 | $902K | $763K | $2.15M | $341K | $80K | $835K | $804K |
| **Operating Cash Flow** | -$1.38M | -$740K | -$1.32M | -$1.45M | -$4.43M | -$2.81M | -$2.28M | -$241K | -$10.93M | -$15.24M |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | $189K | -- | $8.51M | -$8.51M |
| Common Stock Issued | -- | -- | -- | $159K | $420K | -- | $83K | $240K | -- | -- |
| **Financing Cash Flow** | $1.39M | $656K | $1.25M | $1.13M | $4.53M | $3.22M | $2.17M | $240K | -- | -- |
| **Net Change in Cash** | $2.7K | -$84K | -$71K | -$327K | $95K | $412K | $79K | -$980 | -$2.42M | -$23.75M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.16M | $341K | -$2.24M | $250.3M | -$1.11M | $210K | -$364K | -$654K |
| Stock-Based Compensation | $63K | $730K | $1.64M | $0 | $0 | $0 | $0 | $0 |
| Change in Receivables | $0 | $0 | $49K | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$342K | -$92K | -$342K | -$783K | -$307K | -$126K | -$167K | -$104K |
| Common Stock Issued | $6.6K | $6.6K | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $220K | $215K | $317K | $463K | $628K | $135K | $160K | $41K |
| **Net Change in Cash** | -$122K | $122K | -$25K | -$320K | $321K | $8.8K | -$7.0K | -$63K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -9497.2% | -- | -- | -435.7% | -- | -- | -- | -- |
| **Net Profit Margin** | -- | -- | -11290.1% | -- | -- | -545.9% | -- | -- | -- | -- |
| Return on Equity (ROE) | 94.9% | -54.8% | -65.2% | 26.3% | -118.0% | -80.7% | -39.3% | -28.9% | -- | -109.2% |
| Return on Assets (ROA) | 63.4% | -17.0% | -26.3% | 14.1% | -39.8% | -40.2% | -28.0% | -25.9% | -1178.5% | -96.7% |
| Current Ratio | 0.07x | 0.01x | 0.02x | 0.02x | 0.04x | 0.06x | 0.04x | 0.01x | 0.69x | 8.72x |
| Quick Ratio | 0.01x | 0.01x | 0.01x | 0.02x | 0.04x | 0.04x | 0.03x | 0.01x | 0.68x | 7.43x |
| Debt to Equity | -- | 0.29x | 0.15x | 0.02x | 0.05x | 0.01x | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -255.1% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | +5800.0% | -- | -300.0% | -- | -- | -- | -- | -- | -- | -- |
| 10Y Revenue / Share Growth | -- | -- | -99.5% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | 93.9% | 93.6% | 94.0% | 94.9% | -18.4% | -47.3% | -55.0% | -54.8% |
| Return on Assets (ROA) | 62.8% | 62.7% | 62.8% | 63.4% | -5.9% | -14.7% | -16.6% | -17.0% |
| Current Ratio | 0.07x | 0.08x | 0.11x | 0.07x | 0.08x | 0.01x | 0.01x | 0.01x |
| Quick Ratio | 0.00x | 0.01x | 0.00x | 0.01x | 0.02x | 0.01x | 0.01x | 0.01x |
| Debt to Equity | -- | -- | -- | -- | -- | 0.33x | 0.32x | 0.29x |
| **Net Income Growth (YoY)** | -- | +39.7% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
